List view / Grid view



2017 pipelines: AstraZeneca – another challenging year

8 February 2017 | By Brian White and Paul Taylor, Healthcare Analysts, Cantor Fitzgerald Europe

Healthcare analysts predict another difficult year ahead for the pharmaceutical giant, after 2016 was beset with competitive and pricing pressures...

Transforming healthcare in the era of Trump: An opportunity to disrupt

20 January 2017 | By Stephen Klasko, President and CEO, Thomas Jefferson University and Jefferson Health; Editor-in-Chief, Healthcare Transformation

With Trump’s rule imminent, President and CEO of Thomas Jefferson University, Stephen Klasko, puts forth a manifesto for healthcare reform, disruption and change…

Application Notes & Whitepapers 2016

13 December 2016 | By European Pharmaceutical Review

With the huge range of processes involved in drug discovery and manufacture, it's no wonder we had to create a separate magazine for this content – and as such we have a wide variety of applications...

How Trump’s victory will impact Life Sciences

13 December 2016 | By Alex Pye and Mark Brewer, Life Sciences analysts, finnCap

Threats to immediately end Obamacare? Import cheaper drugs from overseas? Analysts Alex Pye and Mark Brewer look to the facts for Trump's pharma impact...

Send this to a friend